INTRODUCTION
============

We live in an era of many medical upheavals. For instance, the development of technology and medical knowledge due to material engineering and basic sciences have led to rapid advances in medical equipment. In addition, rapid changes in national medical policies, such as introduction of telemedicine, abolition of uncovered health services or the reduced workload for residents as 80-hour per week, have changed the medical environment \[[@b16-jkns-2018-0216]\]. Vascular neurosurgeons must adapt to these changes to stay current. Recently, vascular neurosurgery has become more popular, even though it is perceived as 3D-jobs in the neurosurgical field, because vascular neurosurgeons have begun to perform less invasive endovascular treatment as well as the traditional open surgical treatments. In fact, younger vascular neurosurgeons view endovascular treatment as a necessity, not an option, and so-called "hybrid" vascular neurosurgeons who can perform both craniotomies and endovascular surgery are taken for granted. Relatedly, the residents' training regulations of the Korean Neurosurgical Society have been changed to allow more endovascular treatment in training programs.

Although, a considerable proportion of endovascular treatment in South Korea since 1994 has been carried out by neuroradiology doctors, endovascular treatment performed by vascular neurosurgeons had been increased gradually, and they have increased much more since the establishment of standards for the training and certification of endovascular neurosurgery in South Korea has been firstly published \[[@b17-jkns-2018-0216]\]. However, few specific statistics are known regarding how many endovascular treatments are performed by neurosurgeons, so the role of neurosurgeons in this field is unclear. For this reason, the annual reports of the Society of Korean Endovascular Neurosurgeons (SKEN) from 2013 to 2017 have included a statistical report on endovascular treatment performed by or with the participation of vascular neurosurgeons. In the present study, authors compared endovascular treatment cases by vascular neurosurgeons of the SKEN annual reports with data obtained from the nationwide Health Insurance Review and Assessment Service (HIRA) of South Korea from 2013 to 2017. In this way, authors ascertained the pattern of endovascular treatment in South Korea and examined the role of vascular neurosurgeons in the field of endovascular treatment in South Korea.

MATERIALS AND METHODS
=====================

Data collection and period in annual report of SKEN from 2013 to 2017
---------------------------------------------------------------------

The SKEN has been issuing annual reports since 2014; these include statistics on all endovascular treatments performed alone or collaboratively with another clinician, such as a neuroradiologist, by SKEN members between 2013 and 2017. These data were collected using a data sheet that recorded the number of endovascular treatments performed in each year. Firstly, the editorial director of the annual report notified each hospital via e-mail. The hospitals then sent data via e-mail using the data sheet ([Fig. 1](#f1-jkns-2018-0216){ref-type="fig"}). The data were also requested and collected from vascular neurosurgeons of various hospitals, including certified institutions of the SKEN via one-on-one telephone calls and text messages by the editorial director. This data collection was carried out over about 3 months each year from 2014 to 2018. The number of hospitals involved ranged from 77 to 100, and the number of endovascular treatments was assumed to be the number of patients, except in the case of aneurysms, whereby the number of aneurysm itself was recorded. In this regard, the report differed from the HIRA, in which the number of patients with aneurysm was counted. This was taken into account during data analysis. The present study analyzed these clinical data from annual SKEN report between 2013 and 2017.

Data collection and period from the Healthcare Bigdata Hub of HIRA
------------------------------------------------------------------

National statistics on endovascular treatment in South Korea were obtained from the Healthcare Bigdata Hub website of the HIRA. The target period for data collection was also 2013--2017. These data were collected in accordance with the Electronic Data Interchange (EDI) code, which was matched to the endovascular treatments on the data sheet distributed to SKEN members ([Table 1](#t1-jkns-2018-0216){ref-type="table"}). However, in the case of intra-arterial (IA) thrombolysis, data collection was based on a combination of the EDI and I63 codes, a cerebral infarction disease code, because the HIRA provided additional data on combining the EDI and I63 codes. We believe that the combined data are more accurate than data from the EDI code only.

Data analysis
-------------

This study was approved by the Institutional Review Board (IRB) of CHA Bundang Medical Center, CHA Univeristy School of Medicine on July 4th, 2019 as a deliberative exemption (IRB No. CHAMC 2019-06-035). Authors directly compared the data collected from SKEN with the nationwide data from the Healthcare Bigdata Hub of the HIRA. However, the category of extracranial percutaneous transluminal angioplasty or stent including carotid artery stenting ("EC-PTA or stent \[CAS\]") and EC-PTA or stent excluding carotid artery stenting ("EC-PTA or stent \[the rest of CAS\]") in the data collected from SKEN were combined into "EC-PTA or stent (including CAS)" and compared to the "EC-PTA or stent (including CAS)" in HIRA's data. Authors also obtained the ratio between the data collected from SKEN and the nationwide data. Using these data, authors analyzed the flow and trends of endovascular treatments performed in South Korea from 2013 to 2017.

RESULTS
=======

Endovascular treatments performed collaboratively by vascular neurosurgeons from 2013 to 2017
---------------------------------------------------------------------------------------------

In the years 2013 to 2017, 77, 82, 85, 93, and 100 hospitals participated in the survey, respectively. The data for each hospital were analyzed by region and category, and the overall data were analyzed according to each category ([Table 2](#t2-jkns-2018-0216){ref-type="table"}). Regionally, in all the years analyzed, endovascular treatments were most common in Gyeonggi-do, followed by Seoul and Busan ([Fig. 2](#f2-jkns-2018-0216){ref-type="fig"}). With regards to specific endovascular treatments, conventional cerebral angiography was the most common (that is digital subtraction angiography; "DSA"), followed by cerebral aneurysmal coiling and treatments for ischemic stroke, vascular malformation, and tumor embolization ([Fig. 3](#f3-jkns-2018-0216){ref-type="fig"}).

The number of hospitals participating in data collection gradually increased during the study period, as did the number of endovascular treatments performed collaboratively by SKEN members. However, the increase in the number of endovascular treatments was greater than the increase in the number of participating hospitals. Specifically, the rate of increase in each category was higher than the rate of increase in the number of participating hospitals (from 77 to 100; 29.9%), with the exception of "EC-PTA or stent (the rest of CAS)", which increased from 194 to 226 patients (16.5%), and treatment for arteriovenous malformation ("AVM"), which increased from 177 to 221 patients (24.9%) ([Table 2](#t2-jkns-2018-0216){ref-type="table"}). The rates of increase exceeded 50% in "DSA", simple coilings ("coiling"), stent- or balloon-assisted coilings ("stent or balloon"), "IA thrombolysis for cerebral infarction", "EC-PTA or stent (CAS)", "intracranial (IC)-PTA or stent" and dural arteriovenous fistula or carotid- cavernous fistula ("dural AVF or CCF"), especially in the case of "IA thrombolysis for cerebral infarction", which showed an increase of more than 200% ([Table 2](#t2-jkns-2018-0216){ref-type="table"}). The increase in the number of unruptured intracranial aneurysms ("UIA", from 3303 to 5563; 68.4%) was higher than the increase in the number of ruptured aneurysms ("Ruptured", from 1999 to 2838; 42%).

Nationwide data from the Healthcare Bigdata Hub of the HIRA from 2013 to 2017
-----------------------------------------------------------------------------

Nationwide data from the HIRA between 2013 and 2017 were analyzed by region and category, and the overall data were analyzed according to each category ([Tables 3](#t3-jkns-2018-0216){ref-type="table"}-[](#t4-jkns-2018-0216){ref-type="table"}[](#t5-jkns-2018-0216){ref-type="table"}[](#t6-jkns-2018-0216){ref-type="table"}[](#t7-jkns-2018-0216){ref-type="table"}[8](#t8-jkns-2018-0216){ref-type="table"}). Regionally, endovascular treatment was the most common in Seoul, followed by Gyeonggi-do and Busan in all years analyzed. Concerning specific endovascular treatments, "DSA" was the most common, followed by cerebral aneurysmal coiling and treatments for ischemic stroke, vascular malformation, and tumor embolization.

Additionally, national data showed an overall increase in the number of endovascular treatments during the study period, and the rates of increase exceeded 50% in "DSA", aneurysm ("coiling + parent artery occlusion \["PAO"\]" and "stent or balloon"), and "IA thrombolysis for cerebral infarction"; "IA thrombolysis for cerebral infarction" showed an increase of more than 200% ([Table 3](#t3-jkns-2018-0216){ref-type="table"}). The rates of increase were about 40% in "dural AVF or CCF" and "tumor embolization", about 30% in "EC-PTA or stent (including CAS)" and intracranial percutaneous transluminal angioplasty or stent ("IC-PTA or stent"), and about 15% in "AVM".

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA from 2013 to 2017
-------------------------------------------------------------------------------------------------------------------------------------

During the 5 years from 2013 to 2017, SKEN members participated in 50--55% of "DSA", 70--80% of "IA thrombolysis for cerebral infarction", 50--70% of "EC-PTA or stent (including CAS)", 65--85% of "IC-PTA or stent", 60--75% of "AVM", 75--95% of "dural AVF or CCF", 40--60% of "tumor embolization" ([Tables 3](#t3-jkns-2018-0216){ref-type="table"}-[](#t4-jkns-2018-0216){ref-type="table"}[](#t5-jkns-2018-0216){ref-type="table"}[](#t6-jkns-2018-0216){ref-type="table"}[](#t7-jkns-2018-0216){ref-type="table"}[8](#t8-jkns-2018-0216){ref-type="table"}; [Fig. 4](#f4-jkns-2018-0216){ref-type="fig"}). Although the overall number of endovascular treatments performed by SKEN members increased during the study period, there were no significant changes in the categories "DSA", "IA thrombolysis for cerebral infarction", "AVM", "dural AVF or CCF", and "tumor embolization" with regard to the ratio of data from SKEN members to those from HIRA. An increase in the ratio was observed for "EC-PTA or stent (including CAS)" and "IC-PTA or stent" ([Tables 3](#t3-jkns-2018-0216){ref-type="table"}-[](#t4-jkns-2018-0216){ref-type="table"}[](#t5-jkns-2018-0216){ref-type="table"}[](#t6-jkns-2018-0216){ref-type="table"}[](#t7-jkns-2018-0216){ref-type="table"}[8](#t8-jkns-2018-0216){ref-type="table"}). In the category of aneurysm treatments, SKEN members participated in approximately 100--108% of "coiling" and about 60--65% of "stent or balloon" ([Tables 3](#t3-jkns-2018-0216){ref-type="table"}-[](#t4-jkns-2018-0216){ref-type="table"}[](#t5-jkns-2018-0216){ref-type="table"}[](#t6-jkns-2018-0216){ref-type="table"}[](#t7-jkns-2018-0216){ref-type="table"}[8](#t8-jkns-2018-0216){ref-type="table"}). Because the number of aneurysmal treatments involving SKEN members was counted as the number of aneurysms, while the number of aneurysmal treatments in the HIRA was counted as the number of patients, authors could not directly compare the two data sets, so the derived ratios cannot be meaningful (100--108% and 60--65%). During the 5-year study period, there were no significant changes in the ratio of aneurysmal data between SKEN members and the HIRA ([Tables 3](#t3-jkns-2018-0216){ref-type="table"}-[](#t4-jkns-2018-0216){ref-type="table"}[](#t5-jkns-2018-0216){ref-type="table"}[](#t6-jkns-2018-0216){ref-type="table"}[](#t7-jkns-2018-0216){ref-type="table"}[8](#t8-jkns-2018-0216){ref-type="table"}).

In summary, the ratio of data from SKEN members to that from HIRA was about 50--70% for "DSA", aneurysm ("coiling + PAO" and "stent or balloon"), and "AVM", 70--90% for "IA thrombolysis for cerebral infarction" and "dural AVF or CCF", and 45--60% for "tumor embolization"; these ratios did not change much over the 5-year study period. For "EC-PTA or stent (including CAS)" and "IC-PTA or stent", the ratios were 50--70% and 65--85%, respectively, and the increasing trend was significant.

DISCUSSION
==========

Clinical and autopsy studies suggest that intracranial aneurysms have a frequency of 1--8% \[[@b9-jkns-2018-0216]\], and that the incidence of subarachnoid hemorrhage due to ruptured aneurysms ranges from 6 to 8 people per 100,000 in western populations \[[@b5-jkns-2018-0216]\]. In the 1960s, McKissock et al. \[[@b6-jkns-2018-0216]-[@b8-jkns-2018-0216]\] were the first to report some controlled trials into the conservative and surgical treatment of ruptured aneurysms. They showed better outcomes using surgical management \[[@b6-jkns-2018-0216]-[@b8-jkns-2018-0216]\]. Since then, surgical techniques, instruments, and management methods have developed greatly, resulting in better outcomes. In 1991, electrolytically detachable coils (Guglielmi detachable coils; Boston scientific/Target Therapeutics, Freemont, CA, USA) were introduced to treat ruptured aneurysms using an endovascular approach. They were approved by United States Food and Drugs Administration (FDA) in 1995 \[[@b4-jkns-2018-0216]\]. Since then, endovascular coiling has widely been used to treat ruptured and unruptured aneurysms \[[@b1-jkns-2018-0216],[@b2-jkns-2018-0216],[@b15-jkns-2018-0216]\]. In particular, the serial trial known as the International Subarachnoid Aneurysm Trial, which was carried out from 2002 to 2015, proved the efficacy and safety of endovascular coiling methods \[[@b11-jkns-2018-0216]-[@b14-jkns-2018-0216]\]. With these successful trials, endovascular coiling could be recommended in the 2012 guidelines as a first option to treat patients with ruptured aneurysms judged to be technically amenable to both endovascular coiling and neurosurgical clipping \[[@b3-jkns-2018-0216]\]. In unruptured aneurysms, endovascular coiling is associated with lower procedural morbidity and mortality than surgical clipping in selected cases, and it is recommended at Class IIa with Level of Evidence B \[[@b18-jkns-2018-0216]\].

In South Korea, endovascular treatment research meetings began in 1994. In particular, two meetings were started by neurosurgeons and neuroradiologists, respectively. Each meeting then developed into a society : the SKEN, as well as the Korean Society of Interventional Neuroradiology (KSIN). At first, endovascular treatments were mainly performed by neuroradiologists. However, many vascular neurosurgeons eventually became interested and involved in endovascular treatment. Recently, endovascular treatment has been performed by neurosurgeons, neuroradiology doctors, or both, and the specific situations vary among hospitals.

According to data collected from SKEN members over 5 years from 2013 to 2017, the number of endovascular treatments performed collaboratively by SKEN members continuously increased over the period. Big cities such as Gyeonggi-do, Seoul, and Busan led this, but the phenomenon was observed nationwide. Among the endovascular treatments, conventional cerebral angiography was the most common, followed by cerebral aneurysmal coiling, endovascular treatments for ischemic stroke, and finally endovascular treatments for vascular malformation and tumor embolization. With the number of hospitals participating in data collection increasing year by year, it was natural that the total number of endovascular treatments performed would increase ([Fig. 3](#f3-jkns-2018-0216){ref-type="fig"}). However, the rate of increase in endovascular treatments was higher than that participating hospitals; even when each category was analyzed separately, the rate of increase was higher in all categories of endovascular treatment than in the number of participating hospitals, except for the categories of "EC-PTA or stent(the rest of CAS)", and "AVM" ([Table 2](#t2-jkns-2018-0216){ref-type="table"}). In several categories, the rate showed an increase of more than 50%, and in the "IA thrombolysis for cerebral infarction" category it showed an increase of more than 200% ([Table 3](#t3-jkns-2018-0216){ref-type="table"}). This shows that the number of endovascular treatments performed by SKEN members has increased, although this may have been due to the increase in hospital participation in some cases.

According to data collected from SKEN members, the "EC-PTA or stent(the rest of CAS)" category likely showed a lower rate of increase because this category lies outside the traditional remit of neurosurgery, and the absolute case number of such procedures was small. Authors expect that there will be little future change in this category of "EC-PTA or stent". In the category of "AVM", it is likely that trial known as "A Randomized trial of Unruptured Brain Arteriovenous Malformations" (ARUBA) released in 2014 was the cause of the lower rate of increase. In the ARUBA trial, medical management alone was superior to medical management with interventional therapy in the prevention of death or stroke in patients with unruptured brain AVMs \[[@b10-jkns-2018-0216]\]. Therefore, endovascular treatment for unruptured AVM was probably reduced. Unless other studies contradict the results of the ARUBA trail, there may be no change in the rate of increase in the "AVM" category. In the category of aneurysms, there was a higher rate of increase in the number of unruptured aneurysm than in the number of ruptured aneurysms, perhaps because diagnostic tools such as brain computed tomography angiography or magnetic resonance angiography have been developed, or because health screening has been applied nationwide.

According to national data from HIRA from 2013 to 2017, the number of endovascular treatments continuously increased over the 5-year period and were the highest in Seoul, followed by Gyeonggi-do and Busan, which is slightly different from the trend for SKEN data, according to which endovascular treatments were most common in Gyeonggi-do ([Tables 3](#t3-jkns-2018-0216){ref-type="table"}-[](#t4-jkns-2018-0216){ref-type="table"}[](#t5-jkns-2018-0216){ref-type="table"}[](#t6-jkns-2018-0216){ref-type="table"}[](#t7-jkns-2018-0216){ref-type="table"}[8](#t8-jkns-2018-0216){ref-type="table"}). During the study period, the rate of increase in endovascular treatments exceeded 50% in "DSA", aneurysm ("coiling + PAO" and "stent or balloon") and "IA thrombolysis for cerebral infarction", was about 40% in "dural AVF or CCF" and "tumor embolization", and was about 15% in "AVM", which were similar to the results from SKEN data ([Table 3](#t3-jkns-2018-0216){ref-type="table"}). In contrast, the rate of increase was about 30% in "EC-PTA or stent (including CAS)" and "IC-PTA or stent", which was different from the results from SKEN data, according to which the rate of increase was about 70% ([Table 3](#t3-jkns-2018-0216){ref-type="table"}). These results are consistent with the following analysis from a different point of view. Compared with the national data collected from HIRA, there were no significant changes in the ratio of data from SKEN members to data from HIRA in "DSA", aneurysm ("coiling + PAO" and "stent or balloon"), "IA thrombolysis for cerebral infarction", "AVM", "dural AVF or CCF" and "tumor embolization", however, an increase in the ratio was noted for "EC-PTA or stent (including CAS)" and "IC-PTA or stent" ([Table 3](#t3-jkns-2018-0216){ref-type="table"}).

The categories of "DSA" and aneurysm ("coiling" + "PAO" and "stent or balloon") showed a 50--60% ratio for data from SKEN members and from HIRA and "IA thrombolysis for cerebral infarction" showed a 70--80% ratio, which did not change significantly and the rates of increase exceeded 50% during the 5-year study period ([Table 3](#t3-jkns-2018-0216){ref-type="table"}). The reasons might be as follows. Diseases belonging to these categories are representative ones that require endovascular treatment and are quite common, so many of these categories have already been performed by vascular neurosurgeons since 2013. Therefore, this ratio is expected to proceed in a similar trend into the future. And in the category of aneurysmal treatments, the ratio in "coiling" was more than 100%, while in the "stent or balloon" it was 60--65%. The number of aneurysmal treatments involving SKEN members was counted as the number of aneurysms, while the number in the HIRA was counted as the number of patients. Therefore, it was not possible to directly compare the two data sets. However, assuming that multiple aneurysms occur in 25% of cases, SKEN members likely participated in the treatment of more than 50% of aneurysms. In addition, even though the ratio itself was meaningless, there were no significant changes in the ratio of aneurysmal data between SKEN members and the HIRA over the 5-year study period, which may indicate that the data collected by the SKEN were quite reliable. In the category of "IA thrombolysis for cerebral infarction", the rates of increase was above 200%, which was from that the treatment performance improved greatly due to the rapid development of treatment technology in recent years ([Table 3](#t3-jkns-2018-0216){ref-type="table"}). Therefore, the ratio of data from SKEN members to those from HIRA will be similar, but the total number will continue to increase.

"AVM" showed a 60--75% ratio, which did not change significantly during the study period. The rate of increase was about 15--25% during the study period, which was assumed to remain unchanged per the ARUBA trial, as mentioned above. The categories "dural AVF or CCF" and "tumor embolization" showed 75--95% and 40--60% ratios, which did not change significantly over the 5-year study period. The rate of increase was about 40--50% and 36--40%, respectively. Although these categories are not common, they are likely of interest to vascular neurosurgeons. The categories "EC-PTA or stent (including CAS)" and "IC-PTA or stent" showed 50-- 70% and 65--85% ratios, respectively, and the difference in the rate of increase between SKEN members and HIRA was found to be 30--70%. These ratios seem to change from conventional surgical (in the case of "EC-PTA or stent \[including CAS\])" or medical (in the case of "IC-PTA or stent") treatment to endovascular treatment, possibly led by vascular neurosurgeons (SKEN members).

In 1997, Veith \[[@b19-jkns-2018-0216]\], the President of the Society for Vascular Surgery, delivered the Presidential address in celebration of the 50th anniversary of the foundation of the Society. In that speech, he mentioned the threats to the specialized field of vascular surgery, emphasizing that advances in technology have allowed less-invasive, more cost-effective treatments, and that fiscal policy has encouraged it. This has increased the possibility that vascular surgery will become extinct. The less-invasive treatments of vascular disease he mentioned were endovascular treatments such as catheter-guidewire-imaging techniques involving catheters, balloons, atherectomy devices, stents, stented grafts, etc. He thought these were threats to the vascular surgeons because they confer similar or better results to open surgical treatments, and because they can be performed by non-surgical interventional specialists with training in radiology or cardiology \[[@b19-jkns-2018-0216]\]. For this reason, he argued that vascular surgeons must learn and practice endovascular treatment skills, and that, if they do not, they will be culled.

This was the situation in the US vascular surgery (not vascular neurosurgery) around 1997, and it is surprisingly similar to the situation of vascular neurosurgery in South Korea since 1994. At that time, endovascular treatment began in South Korea, but no one could be sure about the potential of the treatment for development. Fortunately, our forerunners had foresight and tried to adapt to these changes in the environment. Since 1994, they have established a research meeting and developed it into a society (SKEN) to continue and expand the role of vascular neurosurgeons. Of course, this development process produced many difficulties. While conventional open surgery was already established, endovascular treatment was a field in which results had to be made: there were many trials and errors, and it was difficult to be recognized by the Korean Neurosurgical Society. Furthermore, there were many conflicts with neuroradiologists, who had already taken an important positions in the field of endovascular treatment. Despite these difficulties, our forerunners did not stop their efforts. As the result, a substantial proportion of endovascular treatment in South Korea is now carried out by vascular neurosurgeons, as shown above. The SKEN, which has grown in quantity and quality, still makes such efforts and will continue to do so.

Limitations of the study
------------------------

The data from the present study were collected from vascular neurosurgeons across the country over 5 years, with 77--100 hospitals involved ([Table 9](#t9-jkns-2018-0216){ref-type="table"}). However, this number does not include all hospitals with vascular neurosurgeons. In other words, the data in this study reflect only a subsection of all vascular neurosurgeons in South Korea. As mentioned earlier, aneurysm cases collected by the SKEN were based on the number of treated aneurysms, while the cases in the HIRA were based on the number of patients. Therefore, it was not possible to directly compare them. If comparisons were made using the same criteria, more accurate results could be obtained.

CONCLUSION
==========

The SKEN members have been responsible for the major role of endovascular treatments in South Korea for the recent 5 years. This was achieved through the perseverance of senior members who started out in the midst of hardship, the establishment of standards for the training/certification of endovascular neurosurgery, and the enthusiasm of current SKEN members who followed. To provide better treatment to patients, we will have to make further progress in SKEN.
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![Required statistical data sheet delivered to SKEN members. The number of aneurysmal treatments reported in this annual report was counted as the number of aneurysms, which is different from the number in the HIRA, which was counted by patient. SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service, DSA : digital subtraction angiography, PAO : parent artery occlusion, UIA : unruptured intracranial aneurysms, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous stula.](jkns-2018-0216f1){#f1-jkns-2018-0216}

![Graphical data from the SKEN members according to region and category in 2017. Endovascular treatments were the most common in Gyeonggi-do, followed by Seoul and Busan. This trend was also observed in all periods from 2013 to 2017. SKEN : The Society of Korean Endovascular Neurosurgeons.](jkns-2018-0216f2){#f2-jkns-2018-0216}

![Serial data from SKEN members according to each category. With the exception of digital subtraction angiography (DSA), cerebral aneurysmal coiling was the most common, endovascular treatments for ischemic stroke were second, followed by endovascular treatments for vascular malformation and tumor embolization. SKEN : The Society of Korean Endovascular Neurosurgeons.](jkns-2018-0216f3){#f3-jkns-2018-0216}

![Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA from 2013 to 2017. SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service.](jkns-2018-0216f4){#f4-jkns-2018-0216}

###### 

Endovascular treatments and EDI codes matched

  Endovascular treatments                                                                    EDI code
  ------------------------------------------------------------------------------------------ -----------------------------------------------------------------------
  DSA                                                                                        HA 601, HA602, HA603, HA604, HA605, HA606, HA691, HA692, HA693, HA694
  Coiling                                                                                    M1662
  Stent or balloon assisted coiling                                                          M1661
  IA thrombolysis for cerebral infarction^[\*](#tfn1-jkns-2018-0216){ref-type="table-fn"}^   M6630, M6631, M6633, M6636 + I63
  Extracranial PTA or Stent                                                                  M6602, M6594
  Intracranial PTA or Stent                                                                  M6601, M6593
  AVM embolization                                                                           M1663, M1667, M1668, M1669
  Dural AVF or CCF embolization                                                              M1664, M1665, M1666
  Tumor embolization                                                                         M1673, M1674, M1675

Exceptionally, in the case of IA thrombolysis, it was based by combining EDI code and I63, a cerebral infarction disease code.

EDI : Electronic Data Interchange, DSA : digital subtraction angiography, IA : intra-arterial, PTA : percutaneous transluminal angioplasty, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Data from SKEN members according to category from 2013 to 2017

  Year                 The number of participating hospitals   DSA     Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                        
  -------------------- --------------------------------------- ------- ------------------- ----------------- ----------------------- -------------------- ------- ------- ------- ------- ------ ------------------------------------------------------- ------- ------- ----- -------
  2013                 77                                      25889   3275                83                1944                    5302                 3303    1999    5302    1179    1197   0                                                       422     177     184   295
  2014                 82                                      28354   3577                77                2211                    5865                 3595    2270    5865    1570    1378   194                                                     466     226     170   258
  2015                 85                                      33537   4022                107               2481                    6610                 4233    2377    6610    1738    1425   300                                                     540     246     243   349
  2016                 93                                      38860   4513                112               3104                    7729                 5030    2699    7729    2187    1598   240                                                     532     249     305   427
  2017                 100                                     44596   4935                118               3348                    8401                 5563    2838    8401    2666    1820   226                                                     719     221     276   401
  Ratio of 2017/2013   129.9                                   172.3   150.7               142.2             172.2                   158.4                168.4   142.0   158.4   226.1   152    116.5^[‡](#tfn4-jkns-2018-0216){ref-type="table-fn"}^   170.4   124.9   150   135.9

The meaning of this \'subtotal\' is the sum of the \'coiling\', \'PAO\' and \'Stent or balloon\'.

The meaning of this \'subtotal\' is the sum of the \'UIA\' and \'Ruputred\'.

Ratio of 2014 to 2017.

SKEN : The Society of Korean Endovascular Neurosurgeons, DSA : digital subtraction angiography, PAO : parent artery occlusion, UIA : unruptured intracranial aneurysms, IA : intra-arterial, ECPTA : extracranial percutaneous transluminal angioplasty, CAS : carotid artery stenting, ICPTA : intracranial percutaneous transluminal angioplasty, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA from 2013 to 2017

  Year                 DSA             Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                                         
  -------------------- --------------- ------------------- ----------------- ----------------------- -------------------- ------- -------------- ------- -------------- ------- ------------- ------- ------------- ------- ------------- ------- ------------- -------
  2013                 25889 (55.6%)   46541               3358 (101.5%)     3307                    1944 (60.1%)         3236    1179 (72.8%)   1620    1197 (52.1%)   2297    422 (66.2%)   637     177 (60.8%)   291     184 (76.0%)   242     295 (47.9%)   616
  2014                 28354 (54.6%)   51975               3654 (98.6%)      3707                    2211 (64.9%)         3409    1570 (83.5%)   1880    1572 (66.7%)   2358    466 (72.5%)   643     226 (61.4%)   368     170 (62.7%)   271     258 (41.5%)   622
  2015                 33537 (49.6%)   67651               4129 (102.0%)     4050                    2481 (67.2%)         3691    1738 (69.0%)   2520    1725 (71.0%)   2431    540 (77.1%)   700     246 (70.7%)   348     243 (85.6%)   284     349 (52.8%)   661
  2016                 38860 (50.5%)   77024               4625 (105.9%)     4369                    3104 (66.3%)         4684    2187 (75.1%)   2912    1838 (68.8%)   2672    532 (73.9%)   720     249 (73.9%)   337     305 (95.3%)   320     427 (59.1%)   722
  2017                 44596 (53.6%)   83268               5053 (108.5%)     4655                    3348 (63.7%)         5258    2666 (77.5%)   3442    2046 (69.9%)   2929    719 (87.2%)   825     221 (66.2%)   334     276 (80.5%)   343     401 (45.7%)   878
  Ratio of 2017/2013   172.3           178.9               150.5             140.8                   172.2                162.5   226.1          212.5   170.9          127.5   170.4         129.5   124.9         114.8   150           141.7   135.9         142.5

These data from SKEN members may include non-cerebral infarction cases, for example, when IA thrombectomy were performed for the thromboembolism that occurred during any endovascular procedures.

SKEN : The Society of Korean Endovascular Neurosurgeons, DSA : digital subtraction angiography, PAO : parent artery occlusion, IA : intra-arterial, EC : extracranial, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, IC : intracranial, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA in 2013

  Category            DSA             Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                                
  ------------------- --------------- ------------------- ----------------- ----------------------- -------------------- ------ -------------- ------ -------------- ------ ------------- ----- ------------- ----- ------------- ----- ------------- -----
  Seoul               3270            14448               774               1163                    218                  833    97             302    164            592    31            171   52            135   55            141   69            366
  Busan               3843            4452                377               312                     315                  385    201            157    164            190    71            60    24            26    24            20    48            45
  Incheon             2207            2048                171               156                     71                   64     83             57     72             85     41            24    9             9     7             0     13            12
  Daegu               2922            3152                307               241                     184                  170    179            200    78             143    14            27    22            20    13            5     3             8
  Gwangju             384             1491                91                85                      57                   56     9              117    26             87     10            38    5             7     3             6     0             0
  Daejeon             1450            1927                205               193                     122                  159    91             81     50             136    31            36    8             9     1             1     1             3
  Ulsan               724             791                 133               13                      69                   167    36             26     18             24     8             5     2             3     7             4     2             3
  Gyeonggi-do         5351            8463                605               497                     446                  671    152            213    235            440    70            117   32            44    49            41    133           143
  Gangwon-do          660             959                 78                62                      64                   59     54             53     66             85     19            21    4             4     7             4     6             4
  Chungcheongbuk-do   974             1272                87                73                      70                   116    39             60     54             88     8             18    0             3     0             1     0             0
  Chungcheongnam-do   509             1225                33                107                     61                   134    12             22     33             93     33            32    1             5     6             3     3             4
  Jeollabuk-do        1264            1854                112               121                     81                   60     42             150    112            135    35            54    1             2     1             3     8             7
  Jeollanam-do        0               109                 0                 0                       0                    0      0              0      0              0      0             0     0             0     0             0     0             0
  Gyeongsangbuk-do    1571            2258                165               49                      61                   155    101            71     73             81     25            21    13            16    5             1     1             2
  Gyeongsangnam-do    207             1570                170               186                     89                   180    61             91     31             97     0             6     1             6     5             11    6             17
  Jeju-do             553             522                 50                49                      36                   27     22             20     21             21     26            7     3             2     1             1     2             2
  Total               25889 (55.6%)   46541               3358 (101.5%)     3307                    1944 (60.1%)         3236   1179 (72.8%)   1620   1197 (52.1%)   2297   422 (66.2%)   637   177 (60.8%)   291   184 (76.0%)   242   295 (47.9%)   616

SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service, DSA : digital subtraction angiography, PAO : parent artery occlusion, IA : intra-arterial, EC : extracranial, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA in 2014

  Category            DSA             Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                                
  ------------------- --------------- ------------------- ----------------- ----------------------- -------------------- ------ -------------- ------ -------------- ------ ------------- ----- ------------- ----- ------------- ----- ------------- -----
  Seoul               3446            15556               733               1218                    256                  825    142            296    177            540    23            127   35            161   40            130   71            390
  Busan               4082            5031                478               346                     386                  462    263            208    224            253    52            60    40            30    28            25    26            38
  Incheon             1922            2276                203               186                     70                   74     113            64     60             64     42            21    16            16    8             5     6             7
  Daegu               3117            3516                346               301                     222                  247    180            258    86             136    17            20    33            31    11            10    4             7
  Gwangju             300             1556                68                60                      82                   77     20             106    20             74     3             33    2             3     0             9     0             0
  Daejeon             1985            2227                337               277                     150                  151    102            95     127            165    38            35    16            15    12            11    18            18
  Ulsan               756             933                 75                33                      33                   120    34             31     10             19     10            7     9             11    4             7     3             7
  Gyeonggi-do         6593            10150               658               582                     548                  771    222            314    368            462    156           157   49            57    46            54    111           128
  Gangwon-do          764             1124                109               96                      57                   56     43             33     85             75     37            36    9             8     3             2     1             2
  Chungcheongbuk-do   504             1005                58                50                      37                   98     23             45     28             53     1             12    0             4     0             0     0             2
  Chungcheongnam-do   731             1430                119               116                     127                  172    33             29     75             109    15            23    5             13    8             4     3             4
  Jeollabuk-do        1249            1798                112               133                     96                   40     136            161    146            165    33            40    1             2     3             5     8             10
  Jeollanam-do        0               302                 0                 1                       0                    4      0              22     0              12     0             11    0             0     0             0     0             0
  Gyeongsangbuk-do    2209            2843                182               75                      58                   139    112            80     96             92     31            27    5             7     3             1     2             1
  Gyeongsangnam-do    356             1575                123               176                     60                   151    86             102    40             99     1             10    3             8     2             6     3             5
  Jeju-do             340             653                 53                57                      29                   22     61             36     30             40     7             24    3             2     2             2     2             3
  Total               28354 (54.6%)   51975               3654 (98.6%)      3707                    2211 (64.9%)         3409   1570 (83.5%)   1880   1572 (66.7%)   2358   466 (72.5%)   643   226 (61.4%)   368   170 (62.7%)   271   258 (41.5%)   622

SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service, DSA : digital subtraction angiography, PAO : parent artery occlusion, IA : intra-arterial, EC : extracranial, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA in 2015

  Category            DSA             Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                                
  ------------------- --------------- ------------------- ----------------- ----------------------- -------------------- ------ -------------- ------ -------------- ------ ------------- ----- ------------- ----- ------------- ----- ------------- -----
  Seoul               6046            19383               852               1180                    421                  948    238            445    379            624    61            157   92            171   95            133   108           394
  Busan               4462            6629                508               393                     387                  468    239            228    186            226    51            50    45            21    21            26    51            28
  Incheon             1789            2693                254               236                     69                   66     83             95     42             64     15            18    9             12    6             3     9             7
  Daegu               2201            4163                262               304                     157                  193    106            267    65             132    10            20    9             23    9             11    1             12
  Gwangju             643             1915                77                68                      54                   52     30             123    14             49     2             16    2             7     10            14    3             1
  Daejeon             2245            2924                368               295                     176                  179    114            97     109            120    37            39    12            12    12            7     10            14
  Ulsan               767             1545                131               69                      51                   151    44             58     17             23     13            21    2             3     3             5     2             20
  Gyeonggi-do         8447            13818               759               675                     679                  922    329            471    417            548    158           150   52            59    47            51    124           132
  Gangwon-do          963             1709                153               131                     65                   69     62             52     111            90     43            56    5             6     8             6     3             2
  Chungcheongbuk-do   432             1815                72                83                      41                   73     43             94     44             64     4             26    0             2     1             0     0             5
  Chungcheongnam-do   769             1874                107               113                     109                  155    32             44     68             129    22            25    6             12    8             5     10            13
  Jeollabuk-do        1151            2067                146               151                     72                   39     49             175    97             137    37            46    5             6     16            11    9             9
  Jeollanam-do        0               543                 0                 11                      0                    12     0              23     0              21     0             8     0             0     0             0     0             1
  Gyeongsangbuk-do    2222            3798                250               128                     66                   164    144            140    99             91     29            35    3             4     2             1     3             3
  Gyeongsangnam-do    926             2004                118               152                     106                  180    162            171    62             88     42            16    1             10    3             9     5             13
  Jeju-do             474             771                 72                61                      28                   20     63             37     15             25     16            17    3             0     2             2     11            7
  Total               33537 (49.6%)   67651               4129 (102.0%)     4050                    2481 (67.2%)         3691   1738 (69.0%)   2520   1725 (71.0%)   2431   540 (77.1%)   700   246 (70.7%)   348   243 (85.6%)   284   349 (52.8%)   661

SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service, DSA : digital subtraction angiography, PAO : parent artery occlusion, IA : intra-arterial, EC : extracranial, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA in 2016

  Category            DSA             Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                                
  ------------------- --------------- ------------------- ----------------- ----------------------- -------------------- ------ -------------- ------ -------------- ------ ------------- ----- ------------- ----- ------------- ----- ------------- -----
  Seoul               8380            21915               1055              1266                    570                  1273   327            502    397            609    85            150   92            167   139           157   168           439
  Busan               4602            7074                548               464                     485                  529    243            231    211            226    35            36    38            26    27            24    47            49
  Incheon             2015            2998                249               261                     81                   71     136            144    67             95     11            13    6             5     5             6     7             10
  Daegu               3894            4983                370               330                     245                  228    260            285    79             137    18            12    12            20    13            13    4             14
  Gwangju             488             2120                63                63                      55                   57     51             142    26             88     2             25    5             8     8             12    2             1
  Daejeon             2061            3305                309               221                     166                  274    124            115    96             157    35            42    19            22    9             5     10            10
  Ulsan               283             1936                101               91                      66                   198    35             52     17             41     12            11    7             10    3             7     5             12
  Gyeonggi-do         8579            15140               938               726                     834                  1076   375            559    455            534    152           183   43            48    61            54    154           139
  Gangwon-do          1514            2042                162               144                     89                   79     93             80     110            85     51            60    7             11    14            8     9             2
  Chungcheongbuk-do   615             2165                85                106                     45                   114    30             86     48             87     13            27    0             3     1             3     1             2
  Chungcheongnam-do   1005            2495                123               134                     158                  228    58             79     65             174    32            41    9             4     10            9     7             6
  Jeollabuk-do        1317            2548                179               209                     119                  55     68             151    96             150    22            46    7             2     10            4     3             8
  Jeollanam-do        0               784                 0                 10                      0                    18     0              71     0              44     0             10    0             0     0             0     0             0
  Gyeongsangbuk-do    2669            4068                292               159                     83                   186    152            137    83             83     29            31    3             4     2             2     4             3
  Gyeongsangnam-do    827             2717                79                123                     87                   273    182            236    58             131    33            22    0             6     3             16    1             19
  Jeju-do             611             734                 72                62                      21                   25     53             42     30             31     2             11    1             1     0             0     5             8
  Total               38860 (50.5%)   77024               4625 (105.9%)     4369                    3104 (66.3%)         4684   2187 (75.1%)   2912   1838 (68.8%)   2672   532 (73.9%)   720   249 (73.9%)   337   305 (95.3%)   320   427 (59.1%)   722

SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service, DSA : digital subtraction angiography, PAO : parent artery occlusion, IA : intra-arterial, EC : extracranial, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

Comparison between data collected from SKEN members and nationwide data from the Healthcare Bigdata Hub of the HIRA in 2017

  Category            DSA             Cerebral aneurysm   Ischemic stroke   Vascular malformation   Tumor embolization                                                                                                                                
  ------------------- --------------- ------------------- ----------------- ----------------------- -------------------- ------ -------------- ------ -------------- ------ ------------- ----- ------------- ----- ------------- ----- ------------- -----
  Seoul               8964            24477               1162              1392                    537                  1468   434            642    427            667    103           195   50            142   91            165   147           531
  Busan               5310            7326                482               478                     418                  566    250            282    214            250    43            48    21            24    32            30    38            49
  Incheon             2470            3525                314               272                     107                  114    161            158    102            125    28            30    5             6     10            7     2             8
  Daegu               4012            4565                501               391                     279                  300    250            263    82             147    16            28    13            24    20            13    4             2
  Gwangju             412             2358                56                55                      53                   48     82             196    41             114    40            22    10            9     1             9     0             0
  Daejeon             2632            3345                340               204                     243                  296    147            130    102            141    37            32    25            20    17            11    8             8
  Ulsan               839             2258                129               82                      142                  227    67             75     32             41     19            15    10            13    6             3     9             15
  Gyeonggi-do         10667           17000               958               741                     857                  1162   507            658    485            607    195           180   45            45    70            62    161           213
  Gangwon-do          1869            2286                192               171                     108                  97     127            114    101            91     39            38    10            12    7             4     6             1
  Chungcheongbuk-do   501             2145                79                121                     111                  142    37             116    73             114    28            42    2             4     0             6     1             3
  Chungcheongnam-do   1602            2576                166               152                     175                  213    73             74     123            147    41            48    8             10    7             4     12            12
  Jeollabuk-do        1088            2508                196               201                     109                  74     42             165    53             179    50            37    7             6     6             7     2             5
  Jeollanam-do        0               700                 0                 19                      0                    26     0              70     0              37     0             8     0             0     0             2     0             0
  Gyeongsangbuk-do    2957            4347                311               158                     116                  213    238            192    140            126    44            47    9             7     2             1     7             5
  Gyeongsangnam-do    726             3193                94                148                     65                   282    197            262    48             118    24            38    2             9     7             15    0             14
  Jeju-do             547             659                 73                70                      28                   30     54             45     23             25     12            17    4             3     0             4     4             12
  Total               44596 (53.6%)   83268               5053 (108.5%)     4655                    3348 (63.7%)         5258   2666 (77.5%)   3442   2046 (69.9%)   2929   719 (87.2%)   825   221 (66.2%)   334   276 (80.5%)   343   401 (45.7%)   878

SKEN : The Society of Korean Endovascular Neurosurgeons, HIRA : the Health Insurance Review & Assessment Service, DSA : digital subtraction angiography, PAO : parent artery occlusion, IA : intra-arterial, EC : extracranial, PTA : percutaneous transluminal angioplasty, CAS : carotid artery stenting, AVM : arteriovenous malformation, AVF : arteriovenous fistula, CCF : carotid-cavernous fistula

###### 

The list of the hospitals participated in the 2018 survey

  Hospital                                                          Regions
  ----------------------------------------------------------------- -------------------
  Gachon University Gill Medical Center                             Incheon
  Catholic Kwandong University International 乳 Mary\'s Hospital    Incheon
  The Catholic University of Korea Daejeon St. Mary\'s Hospital     Daejeon
  The Catholic University of Korea Bucheon St. Mary\'s Hospital     Gyeonggi-do
  The Catholic University of Korea Seoul St. Mary\'s Hospital       Seoul
  The Catholic University of Korea St. Vincent\'s Hospital          Gyeonggi-do
  The Catholic University of Korea Uijeongbu St. Mary\'s Hospital   Gyeonggi-do
  The Catholic University of Korea Incheon St. Mary\'s Hospital     Incheon
  Kyung Hee University Hospital at Gangdong                         Seoul
  Ulsan University Gangneung Asan Hospital                          Gangwon-do
  Kangwon National University Hospital                              Gangwon-do
  Konkuk University Hospital                                        Chungcheongbuk-do
  Konyang University Hospital                                       Daejeon
  Gumdan Top General Hospital                                       Incheon
  Kyungpook National University Hospital                            Daegu
  Gyeongsang National University Hospital                           Gyeongsangnam-do
  Kyunghee National University Hospital                             Seoul
  Kyunghee University Medical Center E&C Jungang General Hospital   Gyeongsangnam-do
  Keimyung University Dongsan Medical Center                        Daegu
  Korea University Ansan Hospital                                   Gyeonggi-do
  Kosin University Gospel Hospital                                  Busan
  National Medical Center                                           Seoul
  Bongseng Memorial Hospital                                        Busan
  Namyangju Hanyang General Hospital                                Gyeonggi-do
  New Korea Hospital                                                Gyeonggi-do
  Dankook University Hospital                                       Chungcheongnam-do
  Daegu Catholic University Medical Center                          Daegu
  Daegu Fatima Hospital                                             Daegu
  Sun Medical Center                                                Daejeon
  Daejeon Hankook Hospital                                          Daejeon
  Dongkang Medical Center                                           Ulsan
  Dongguk University Gyeongju Hospital                              Gyeongsangbuk-do
  Dongguk University Ilsan Hospital                                 Gyeonggi
  Donggunsan General Hospital                                       Jeollabuk-do
  Dongrae-Bongseng Hospital                                         Busan
  Dong-A University Hospital                                        Busan
  Dong-Eui Medical Center                                           Busan
  Mediplex Sejong Hospital                                          Gyeonggi-do
  Myongji Hospital                                                  Gyeonggi-do
  Myongji St. Mary\'s Hospital                                      Seoul
  Pusan National University Hospital                                Busan
  Seoul National University Bundang Hospital                        Gyeonggi-do
  Bundang Jesaeng Hospital                                          Gyeonggi-do
  Seodaegu Hospital                                                 Daegu
  Ulsan University Asan Medical Center                              Seoul
  Seoul Medical Center                                              Seoul
  SMG-SNU Boramae Medical Center                                    Seoul
  Kangbuk Samsung Hospital                                          Seoul
  Sungkyunkwan University Samsung Changwon Hospital                 Gyeongsangnam-do
  Pohang Semyoung Christian Hospital                                Gyeongsangbuk-do
  Soon Chun Hyang University Hospital Gumi                          Gyeongsangbuk-do
  Soon Chun Hyang University Hospital Bucheon                       Gyeonggi-do
  Soon Chun Hyang University Hospital Seoul                         Seoul
  Soon Chun Hyang University Hospital Cheonan                       Chungcheongnam-do
  Asan Chungmu Hospital                                             Chungcheongnam-do
  Ajou University Hospital                                          Gyeonggi-do
  Andong Medical Group Hospital                                     Gyeongsangbuk-do
  Andong Sungso Hospital                                            Gyeongsangbuk-do
  Pohang Stroke and Spine Hospital                                  Gyeongsangbuk-do
  Yonsei University Gangnam Severance Hospital                      Seoul
  Yonsei University Severance Hospital                              Seoul
  Wonju Severance Christian Hospital                                Gangwon-do
  Yeungnam University Medical Center                                Daegu
  Presbyterian Medical Center                                       Jeollabuk-do
  On Hospital                                                       Busan
  Ulsan University Ulsan Hospital                                   Ulsan
  Wonkwang University Hospital                                      Jeollabuk-do
  Sun Medical Center                                                Daejeon
  Eulji University Nowon Eulji Medical Center                       Seoul
  Eulji University Daejeon Eulji Medical Center                     Daejeon
  Ewha Womans University Mokdong Hospital                           Seoul
  Hallym Hospital                                                   Incheon
  Inje University Seoul Paik Hospital                               Seoul
  Inje University Haeundae Paik Hospital                            Busan
  Inha University Hospital                                          Incheon
  Chonnam National University Hospital                              Gwangju
  Chonbuk National University Hospital                              Jeollabuk-do
  Jeju National University Hospital                                 Jeju
  Cheju Halla General Hospital                                      Jeju
  Chosun University Hospital                                        Gwangju
  Chung-Ang University Hospital                                     Seoul
  VHS Medical Center                                                Seoul
  CHA University Kumi Medical Center                                Gyeongsangbuk-do
  CHA University Bundang Medical Center                             Gyeonggi-do
  Chamjoeun Hospital                                                Gyeonggi-do
  Cheonan Chungmu Hospital                                          Chungcheongnam-do
  Cheongju St. Mary\'s Hospital                                     Chungcheongbuk-do
  Hankook General Hospital                                          Chungcheongbuk-do
  Chungnam National University Hospital                             Daejeon
  Pohang St. Mary\'s Hospital                                       Gyeongsangbuk-do
  Hallym University Kangnam Sacred Heart Hospital                   Seoul
  Hallym University Kangdong Sacred Heart Hospital                  Seoul
  Hallym University Dongtan Sacred Heart Hospital                   Gyeonggi-do
  Hallym University Chuncheon Sacred Heart Hospital                 Gangwon-do
  Hallym University Medical Center                                  Gyeonggi-di
  Hallym University Hangang Sacred Heart Hospital                   Seoul
  Hanyang University Guri Hospital                                  Gyeonggi-do
  Hanyang University Seoul Hospital                                 Seoul
  Hongik Hospital                                                   Seoul
  Hyosung Hospital                                                  Chungcheongbuk-do
